Mechanisms of asthma

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 1, 1997, Pages 10-16

  Li, James T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEINASE INHIBITOR; TACHYKININ RECEPTOR;

ADOLESCENT; ADULT; ASTHMA; BRONCHUS; CHILD; DRUG ANTAGONISM; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; ADULT; ASTHMA; BRONCHI; CHILD; CHILD, PRESCHOOL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; NEUROPEPTIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEASE INHIBITORS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, IGE; RECEPTORS, TACHYKININ;

EID: 0030642340     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199701000-00003     Document Type: Article

References (47)

1. Holberg CJ, Elston RC, Halonen M, Wright AL, Taussig LM, Morgan WJ, Martinez FD: Segregation analysis of physician-diagnosed asthma in hispanic and non-hispanic white families: a recessive component? Am J Respir Crit Care Med 1996, 154:144-150.
2. Sarafino EP, Goldfedder J: Genetic factors in the presence, severity, and triggers of asthma. Arch Dis Child 1995, 73:112-116.
3. Sandford A, Weir T, Paré: The genetics of asthma. Am J Respir Crit Care Med 1996, 153:1749-1765. A comprehensive review describing various approaches to the study of the genetics of asthma.
4. Meyers DA, Bleecker ER: Approaches to mapping genes for allergy and asthma. Am J Respir Crit Care Med 1995, 152:411-413.
5. Panhuysen CIM, Meyers DA, Postma DS, Bleecker ER: The genetics of asthma and atopy. Allergy 1995, 50:863-869.
6. van Herwerden L, Harrap SB, Wong ZYH, Abramson MJ, Kutin JJ, Forbes AB, Raven J, Lanigan A, Walters EH: Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet 1995, 346:1262-1265. This linkage study demonstrated the association of asthma and bronchial hyperresponsiveness to the fifth intron of the FcERIB gene.
7. Hill MR, James AL, Faux JA, Ryan G, Hopkin JM, le Söuef P, Musk AW, Cookson WOCM: Fcε RI-β polymorphism and risk of atopy in a general population sample. BMJ 1995, 311:776-779.
8. Shirakawa T, Hashimoto T, Furuyama T, Takeshita T, Morimoto K: Linkage between severe atopy and chromosome 11q13 in Japanese families. Clin Genet 1994, 46:228-232.
9. Shirakawa T, Li A, Dubowitz M, Dekker JW, Shaw AE, Faux JA, Ra C, Cookson WOCM, Hopkin JM: Association between atopy and variants of the β subunit of the high-affinity immunoglobulin E receptor. Nat Genet 1994, 7:125-130.
10. Martinati LC, Trabetti E, Casartelli A, Boner AL, Pignatti PF: Affected sibpair and mutation analyses of the high affinity IgE receptor beta chain locus in Italian families with atopic asthmatic children. Am J Respir Crit Care Med 1996, 153:1682-1685.
11. Duffy DL, Healey SC, Chenevix-Trench G, Martin NG: Atopy in Australia [letter]. Nat Genet 1995, 10:260.
12. Hizawa N, Yamaguchi E, Furuya K, Ohnuma N, Kodama N, Kojima J, Ohe M, Kawakami Y: Association between high serum total IgE levels and D11S97 on chromosome 11q13 in Japanese subjects. J Med Genet 1995, 32:363-369.
13. Doull IJM, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, Holgate ST, Morton NE: Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med 1996, 153:1280-1284. This study demonstrates allelic linkage of bronchial hyperresponsiveness to genetic markers on chromosome 11 and of total IgE to the interleukin 9 locus.
14. 2 adrenoceptor polymorphisms: are they clinically important? Thorax 1996, 51:351-353.
15. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995, 345:1213-1214.
16. 2-adrenergic receptor may be important in asthma. The Gly 16 variant was linked to nocturnal asthma in this study.
17. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995, 13:25-33.
18. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Schou C, Beaty TH: Genetic basis of IgE responsiveness: relevance to the atopic diseases. Int Arch Allergy Immunol 1995, 10725-28.
19. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L: Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995, 25:74-78.
20. Song Z, Casolaro V, Chen R, Georas SN, Monos D, Ono SJ: Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996, 156:424-429.
21. Moffatt MF, Hill MR, Cornélis F, Schou C, Faux JA, Young RP, James AL, Ryan G, le Souef P, Musk AW, et al.: Genetic linkage of T-cell receptor α/γ complex to specific IgE responses. Lancet 1994, 343:1597-1600.
22. Editorials: T cell receptor genetics, autoimmunity and asthma. Thorax 1995, 50:919-922.
23. Editorials: HLA genetics and allergic disease. Thorax 1995, 50:815-818.
24. Barnes PJ: NO or no NO in asthma? Thorax 1996, 51:218-220.
25. Fischer A, Hoffmann B: Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man: correlation with neuropeptides. Am J Respir Crit Care Med 1996, 154:209-216.
26. Belvisi M, Barnes PJ, Larkin S, Yacoub M, Tadjkarimi S, Williams TJ, Mitchell JA: Nitric oxide synthase activity is elevated in inflammatory lung disease in humans. Eur J Pharmacol 1995, 283:255-258.
27. Satouchi M, Maeda H, Yu Y, Yokoyama M: Clinical significance of the increased peak levels of exhaled nitric oxide in patients with bronchial asthma. Intern Med 1996, 35:270-275. Concentrations of exhaled NO in asthmatic subjects are correlated with clinical indicators of asthma. Asthma symptoms, peak expiratory flow rate, and sputum eosinophilia correlate directly with exhaled NO.
28. Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM: Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med 1995, 152:800-803.
29. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454-457.
30. Kharitonov SA, Yates DH, Chung KF, Barnes PJ: Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996, 9:196-201.
31. Martin U, Bryden K, Devoy M, Howarth P: Allergens, IgE, mediators, inflammatory mechanisms: increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996, 97:768-772. Subjects with allergic rhinitis also show increased levels of exhaled NO.
32. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM: Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996, 153:1510-1514.
33. Yates DH, Kharitonov A, Thomas PS, Barnes PJ: Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996, 154:247-250.
34. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ: Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995, 152:892-896.
35. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, Johnson DC: Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med 1996, 153:128-135.
36. Pfeffer KD, Ellison G, Robertson D, Day RW: The effect of inhaled nitric oxide in pediatric asthma. Am J Respir Crit Care Med 1996, 153:747-751.
37. Editorial: Airway neuropeptides and neutral endopeptidase in asthma. Clin Exp Allergy 1996, 26:491-493.
38. 3 tachykinin-receptor genes in human lung. Am J Physiol 1995, 269:L309-L317. Lung tissue from individuals with obstructive lung diseases had different profiles of tachykinin-receptor gene expression as compared with normal lung.
39. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K: Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995, 151:613-617.
40. Roisman GL, Lacronique JG, Desmazes-Dufeu N, Carré C, Le Cae A, Dusser DJ: Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1996, 153:381-390.
41. Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM: Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 1995, 151:548-553.
42. Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate ST, Polak JM: Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 1995, 13:288-296.
43. Crimi N, Polosa R, Pulvirenti G, Magri S, Santonocito G, Prosperini G, Mastruzzo C, Mistretta A: Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma. Thorax 1995, 50:505-510.
44. Diamant Z, Van Der Veen H, Kuijpers EAP, Bakker PF, Sterk PJ: The effect of inhaled thiorphan on allergen-induced airway responses in asthmatic subjects. Clin Exp Allergy 1996, 26:525-532.
45. Joos GF, van Schoor J, Kips JC, Pauwels RA: The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am J Respir Crit Care Med 1996, 153:1781-1784.
46. 1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Respir Crit Care Med 1995, 152:879-884.
47. Ichinose M, Miura M, Yamauchi H, Kageyama N, Tomaki M, Oyake T, Ohuchi Y, Hida W, Miki H, Tamura G, Shirato K: A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med 1996, 153:936-941.